Cutaneous and Mucocutaneous Leishmaniasis.
Leishmaniasis cutánea y mucocutánea.
Clinical manifestations
Cutaneous leishmaniasis
Diagnosis
Diagnóstico
Leishmaniasis cutánea
Leishmaniasis mucocutánea
Manifestaciones clínicas
Mucocutaneous leishmaniasis
Tratamiento
Treatment
Journal
Actas dermo-sifiliograficas
ISSN: 2173-5778
Titre abrégé: Actas Dermosifiliogr (Engl Ed)
Pays: Spain
ID NLM: 101777537
Informations de publication
Date de publication:
27 Feb 2021
27 Feb 2021
Historique:
received:
29
12
2020
revised:
11
02
2021
accepted:
13
02
2021
pubmed:
3
3
2021
medline:
3
3
2021
entrez:
2
3
2021
Statut:
aheadofprint
Résumé
Leishmaniasis is a chronic disease caused by flagellate protozoa of the genus Leishmania. It is a global disease, but most cases are seen in South America, the Mediterranean, and some areas of Asia and Africa. The 3 main types of leishmaniasis are cutaneous (the most common), mucocutaneous, and visceral (the most severe). Visceral leishmaniasis is also known as kala-azar. Leishmaniasis is diagnosed by demonstrating the presence of Leishmania amastigotes in clinical specimens using direct microscopic examination or molecular analysis. Various treatments exist, although the evidence supporting the options available for cutaneous leishmaniasis is weak. Both the classical presentation of leishmaniasis and our management of the disease have changed in recent decades because of acquired immune deficiency caused by conditions such as HIV infection or the use of TNF inhibitors.
Identifiants
pubmed: 33652011
pii: S0001-7310(21)00108-3
doi: 10.1016/j.ad.2021.02.008
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
spa
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2021 AEDV. Publicado por Elsevier España, S.L.U. All rights reserved.